MARKET

TXMD

TXMD

TherapeuticsMD
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.060
-0.090
-4.19%
After Hours: 2.060 0 0.00% 19:40 02/21 EST
OPEN
2.150
PREV CLOSE
2.150
HIGH
2.170
LOW
2.020
VOLUME
4.48M
TURNOVER
--
52 WEEK HIGH
6.09
52 WEEK LOW
1.820
MARKET CAP
558.62M
P/E (TTM)
-2.9838
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of TXMD and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average TXMD stock price target is 8.75 with a high estimate of 16.00 and a low estimate of 2.000.

EPS

TXMD News

More
  • H.C. Wainwright Maintains Buy on TherapeuticsMD, Lowers Price Target to $6
  • Benzinga · 13h ago
  • TherapeuticsMD, Inc. (TXMD) CEO Robert Finizio on Q4 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript · 1d ago
  • DPZ, ETFC, VIAC and TXMD among midday movers
  • Seeking Alpha - Article · 1d ago
  • TherapeuticsMD +10% premarket on Q4 results
  • seekingalpha · 1d ago

Industry

Pharmaceuticals
+0.90%
Pharmaceuticals & Medical Research
+0.70%

Hot Stocks

Symbol
Price
%Change
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

About TXMD

TherapeuticsMD, Inc. is a women's healthcare company engaged in creating and commercializing products for women. The Company is focused on pursuing regulatory approvals and pre-commercialization activities necessary for commercialization of its hormone therapy pharmaceutical products. Its drug candidates used in clinical trials are designed to alleviate symptoms of and reduce health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis and vaginal discomfort. With its SYMBODA technology, it is developing hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through dosage forms and administration routes. Its product line includes vitaTrue, vitaPearl, vitaMedMD Plus, vitaMedMD One Prenatal Multivitamin, vitaMedMD Plus Rx Prenatal Multivitamin, vitaMedMD One Rx Prenatal Multivitamin, vitaMedMD Iron 21/7, vitaMedMD Vitamin D3 50,000 IU, BocaGreenMD Prena1 Pearl and BocaGreenMD Prena1 Chew.
More

Webull offers kinds of TherapeuticsMD Inc stock information, including NASDAQ:TXMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TXMD stock news, and many more online research tools to help you make informed decisions.